nach oben

Journal of Neural Transmission

Erschienen in:

30.11.2018 | Neurology and Preclinical Neurological Studies - Original Article

Headache in the course of multiple sclerosis: a prospective study

verfasst von: Marcel Gebhardt, Peter Kropp, Frank Hoffmann, Uwe K. Zettl

Erschienen in: Journal of Neural Transmission | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Multiple sclerosis (MS) is the most common immune-mediated inflammatory disease of the central nervous system (CNS). Early diagnosis and treatment is important to prevent progression of disability in the course of the chronic disease. Therefore, correct and fast identification of early symptoms is vital. Headache is generally not recognized as an early symptom of MS, although numerous studies could show a high prevalence of headache in MS patients. The most common misdiagnosis is migraine. The aim of this study is to investigate the prevalence as well as the phenomenology of headache in MS especially with regard to the progression of the disease. In a prospective, multicenter study, we unbiasedly recruited 150 patients with manifest MS based on the criteria of McDonald. 50 patients at the timepoint of initial diagnosis and 100 of them with a long-term course of the disease were included. Based on a semi-structured interview, we evaluated the occurrence of headache over the last 4 weeks as well as case history, clinical–neurological investigation and questionnaires about depression, fatigue, and quality of life. Prevalence of headache in all patients was 67%. Patients at the timepoint of symptom manifestation of MS showed the highest prevalence of headache that was ever been recorded of 78%. In general, patients with headache were younger, had a shorter duration of the disease, and were less physically affected. We noticed frequent occurrence of migraine and migraine-like headache. In the course of the disease, patients without disease-modifying drug (DMD) complained more frequently headaches than patients with any kind of therapy. Headache is an important early symptom of MS. This could be shown especially among 78% of patients with clinically isolated syndrome (CIS). Therefore, young people with frequent headache should undergo MRI of the head and in the case of abnormal findings a consecutive detailed differential diagnosis. This could reduce the latency until final diagnosis of MS, which is in general much too long. That way these patients could get the earliest possible treatment, which is important to stop the progression of the disease.

Absinta M, Rocca MA, Colombo B, Copetti M, De Feo D, Falini A, Comi G, Filippi M (2012) Patients with migraine do not have MRI-visible cortical lesions. J Neurol 259:2695–2698PubMedCrossRef

Achiron A, Givon U, Magalashvili D, Dolev M, Liraz Zaltman S, Kalron A, Stern Y, Mazor Z, Ladkani D, Barak Y (2015) Effect of Alfacalcidol on multiple sclerosis-related fatigue: a randomized, double-blind placebo-controlled study. Mult Scler 21(6):767–775PubMedCrossRef

Alcaide-Leon P, Cybulsky K, Sankar S, Casserly C, Leung G, Hohol M, Selchen D, Montalban X, Bharatha A, Oh J (2018) Quantitative spinal cord MRI in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm 5(2):e436PubMedPubMedCentralCrossRef

Asseyer S, Schmidt F, Chien C, Scheel M, Ruprecht K, Bellmann-Strobl J, Brandt AU, Paul F (2018) Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin 4(3):2055217318796684PubMedPubMedCentral

Azevedo CJ, Overton E, Khadka S, Buckley J, Liu S, Sampat M, Kantarci O, Lebrun Frenay C, Siva A, Okuda DT, Pelletier D (2015) Early CNS neurodegeneration in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm 2(3):e102PubMedPubMedCentralCrossRef

Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Personal Assess 67:588–597CrossRef

Bermel RA, Weinstock-Guttman B, Bourdette D, Foulds P, You X, Rudick RA (2010) Intramuscular interferon beta-1a therapy in patients with relapsing–remitting multiple sclerosis: a 15-year follow-up study. Mult Scler 16(5):588–596PubMedCrossRef

Bevan CJ, Cree BA (2014) Disease activity free status—a new endpoint for a new era in multiple sclerosis. JAMA Neurol 71(3):269–270PubMedCrossRef

Boneschi FM, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, Solaro C, Comi G (2008) Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 14:514–521CrossRef

Bracci-Laudiero L, Aloe L, Buanne P, Finn A, Stenfors C, Vigneti E, Theodorsson E, Lundeberg T (2002) NGF modulates CGRP synthesis in human B-lymphocytes: a possible anti-inflammatory action of NGF? J Neuroimmunol 123(1–2):58–65PubMedCrossRef

Chavarro VS, Mealy MA, Simpson A, Lacheta A, Pache F, Ruprecht K, Gold SM, Paul F, Brandt AU, Levy M (2016) Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 3(6):e286PubMedPubMedCentralCrossRef

Cohen BA, Rivera VM (2010) PRISMS: the story of a pivotal clinical trial series in multiple sclerosis. Curr Med Res Opin 26(4):827–838PubMedCrossRef

Comi G, Leocani L, Rossi P, Colombo B (2001) Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol 248(3):174–179PubMedCrossRef

Comi G, Martinelli V, Rodegher M, Moiola L, Bajenaru O, Carra A, Elovaara I, Fazekas F, Hartung HP, Hillert J, King J, Komoly S, Lubetzki C, Montalban X, Myhr KM, Ravnborg M, Rieckmann P, Wynn D, Young C, Filippi M (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (precise study): a randomised, double-blind, placebo-controlled trial. Lancet 374:1503–1511PubMedCrossRef

D’Amico D, La Mantia L, Rigamonti A, Usai S, Mascoli N, Milanese C, Bussone G (2004) Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 24:980–984PubMedCrossRef

De Stefano N, Stromillo ML, Rossi F, Battaglini M, Giorgio A, Portaccio E, Hakiki B, Malentacchi G, Gasperini C, Santangelo M, Bartolozzi ML, Sormani MP, Federico A, Amato MP (2011) Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. PLoS One. https://doi.org/10.1371/journal.pone.0019452 PubMedPubMedCentralCrossRef

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À, MAGNIMS study group (2018) Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations. Mult Scler 24(2):214–221PubMedCrossRef

Ergün U, Özer G, Sekercan S, Artan E, Kudiaki C, Ücler S, Coskun Ö, Inan L (2009) Headache in the different phases of relapsing-remitting multiple sclerosis. Neurologist 15:212–216PubMedCrossRef

Fiesseler FW, Shih R, Szucs P, Silverman ME, Eskin B, Clement M, Saxena R, Allegra J, Riggs RL, Majlesi N (2011) Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial. J Emerg Med 40(4):463–468PubMedCrossRef

Flachenecker P, Zettl U, Götze U, Haas J, Schimrigk S, Elias W, Pette M, Eulitz M, Hennig M, Bertram J, Hollweck R, Neiss A, Daumer M, Pitschnau-Michel D, Rieckmann P (2005) MS registry in Germany—design and first results of the pilot phase. Nervenarzt 76(8):967–975PubMedCrossRef

Flachenecker P, Stuke K, Elias W, Freidel M, Haas J, Pitschnau-Michel D, Schimrigk S, Zettl U, Rieckmann P (2008) Multiple sclerosis registry in Germany: results of the extension phase 2005/2006. Dtsch Ärztebl 105(7):113–119

Flachenecker P, Kobelt G, Berg J, Capsa D, Gannedahl M, European Multiple Sclerosis Platform (2017) New insights into burden and costs of multiple sclerosis in Europe: results of Germany. Mult Scler 23(2_suppl):78–90. https://doi.org/10.1177/1362458517708141 PubMedCrossRef

Fox EJ, Rhoades RW (2012) New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis. Curr Opin Neurol Supplz. https://doi.org/10.1097/01.wco.0000413320.94715.e9 CrossRef

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J, MAGNIMS study group (2018) The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol 14(4):199–213PubMedCrossRef

Granberg T, Martola J, Kristoffersen-Wiberg M, Aspelin P, Fredrikson S (2013) Radiologically isolated syndrome–incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scl 19(3):271–280CrossRef

Headache Classification Committee of the International Headache Society (2013) The international classification of headache disorders, 3rd edition. Cephalalgia 33: 629–808CrossRef

Howell O, Reeves C, Nicholas R, Carassiti D, Radotra B, Gentleman S, Serafini B, Aloisi F, Roncaroli F, Magliozzi R, Reynolds R (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134:2755–2771PubMedCrossRef

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS) (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflamm 13(1):280CrossRef

Kantarci OH, Lebrun C, Siva A, Keegan MB, Azevedo CJ, Inglese M, Tintoré M, Newton BD, Durand-Dubief F, Amato MP, De Stefano N, Sormani MP, Pelletier D, Okuda DT (2016) Primary progressive multiple sclerosis evolving from radiologically isolated syndrome. Ann Neurol 79(2):288–294PubMedCrossRef

Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Bauer L, Jakobs P, Pohl C, Sandbrink R (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 67(7):1242–1249PubMedCrossRef

Kister I, Caminero AB, Monteith TS, Soliman A, Bacon TE, Bacon JH, Kalina JT, Inglese M, Herbert J, Lipton RB (2010) Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain 11.5:417–425CrossRef

Klein M, Woehrl B, Zeller G, Straube A (2013) Stabbing headache as a sign of relapses in multiple sclerosis. Headache 53:1159–1161PubMedCrossRef

Kobelt G, Berg J, Lindgren P, Jönsson B (2006) Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 77(8):918–926PubMedPubMedCentralCrossRef

Kovacs K, Bors L, Tothfalusi L, Jelencsik I, Bozsik G, Kerenyi L, Komoly S (1989) Cerebrospinal fluid (CSF) investigations in migraine. Cephalalgia 9(1):53–57PubMedCrossRef

Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA, CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2017) Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study. Neurology 89(24):2455–2461PubMedPubMedCentralCrossRef

Kropp P, Müller B, Barchmann D, Angeli A, Straube A (2011) Does multiple sclerosis facilitate migraine. Fortschr Neurol Psychiatr 79(8):467–469PubMedCrossRef

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33.11:1444–1452CrossRef

Lebrun C (2015) The radiologically isolated syndrome. Rev Neurol (Paris) 171(10):698–706CrossRef

Levy D (2009) Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep 13(3):237–240PubMedCrossRef

Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130(4):1089–1104PubMedCrossRef

Magliozzi R, Howell O, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R (2010) A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 68(4):477–493PubMedCrossRef

Makhani N, Lebrun C, Siva A, Brassat D, Carra Dallière C, de Seze J, Du W, Durand Dubief F, Kantarci O, Langille M, Narula S, Pelletier J, Rojas JI, Shapiro ED, Stone RT, Tintoré M, Uygunoglu U, Vermersch P, Wassmer E, Okuda DT, Pelletier D (2017) Radiologically isolated syndrome in children: clinical and radiologic outcomes. Neurol Neuroimmunol Neuroinflamm 4(6):e395PubMedPubMedCentralCrossRef

Marrie RA (2017) Comorbidity in multiple sclerosis: implications for patient care. Nat Rev Neurol 13(6):375–382PubMedCrossRef

Masters-Israilov A, Robbins MS (2017) Headache in neuromyelitis optica. Curr Pain Headache Rep 21(4):20PubMedCrossRef

Melo-Carrillo A, Strassmann AM, Nir RR, Schain A, Noseda R, Stratton J, Burstein R (2017) Fremanezumab—a humanized monoclonal anti-CGRP antibody—inhibits thinly myelinated (Aδ) but not unmyelinated (C) meningeal nociceptors. J Neurosci. 37(44):10587–10596PubMedPubMedCentralCrossRef

Miller DH, Leary SM (2009) Treatment of clinically isolated syndrome: to be PreCISe. Lancet 374:1475–1476PubMedCrossRef

Mizuno Y, Shinoda K, Watanabe M, Matsushita T, Yamasaki R, Kira JI (2018) Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms in NMOSD. Neurol Neuroimmunol Neuroinflamm 5(3):e447PubMedPubMedCentralCrossRef

Möhrke J, Kropp P, Zettl UK (2013) Headaches in multiple sclerosis patients might imply an inflammatorial process. PLoS One. https://doi.org/10.1371/journal.pone.0069570 PubMedPubMedCentralCrossRef

Moisset X, Ouchchane L, Guy N, Bayle DJ, Dallel R (2013) Migraine headaches and pain with neuropathic characteristics: comorbid conditions in patients with multiple sclerosis. Pain 154:2691–2699PubMedCrossRef

Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH (2018) Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 5(4):e466PubMedPubMedCentralCrossRef

Müller B, Baum A, Holzhausen M, Grittner U, Hilgendorf I, Martus P, Altiner A, Evers S, Rolfs A, Zettl UK, Kropp P (2014) The Rostock Headache Questionnaire (“Rokoko”)—validation of a tool to screen and to qualify primary headaches. Fortschr Neurol Psychiatr 82(3):145–148PubMedCrossRef

Nicoletti A, Patti F, Lo Fermo S, Liberto A, Castiglione A, Laisa P, Garifoli A, La Naia F, Maimone D, Sorbello V, Contrafatto D, Zappia M (2008) Headache and multiple sclerosis: a population-based case–control study in Catania, Sicily. Cephalalgia 28:1163–1169PubMedCrossRef

Patejdl R, Zettl UK (2017) Spasticity in multiple sclerosis: Contribution of inflammation, autoimmune mediated neuronal damage and therapeutic interventions. Autoimmun Rev 16(9):925–936PubMedCrossRef

Penner IK, Paul F (2017) Fatigue as a symptom or comorbidity of neurological diseases. Nat Rev Neurol. (11):662–675

Penner IK, Raselli C, Stöcklin M, Opwis K, Kappos L (2007) The FSMC (Fatigue Scale for Motor and Cognitive Functions)—a new instrument to assess MS-related fatigue. Mult Scler 13:238CrossRef

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302PubMedPubMedCentralCrossRef

Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener HC, Katsarava Z (2009) Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 16:262–267PubMedCrossRef

Reder AT, Ebers GC, Traboulsee A, Li D, Langdon D, Goodin DS, Bogumil T, Beckmann K, Konieczny A, Investigators of the 16-Year Long-Term Follow-Up Study (2010) Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS. Neurology 74(23):1877–1885PubMedCrossRef

Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378(2):169–180. https://doi.org/10.1056/NEJMra1401483 CrossRefPubMedPubMedCentral

Rovaris M, Bozzali M, Rocca MA, Colombo B, Filippi M (2001) An MR study of tissue damage in the cervical cord of patients with migraine. J Neurol Sci 183(1):43–46PubMedCrossRef

Russell FA, King R, Smillie SJ, Kodji X, Brain SD (2014) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94(4):1099–1142PubMedPubMedCentralCrossRef

Skierlo S, Rommer PS, Zettl UK (2016) Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry. Acta Neurol Scand. https://doi.org/10.1111/ane.12612 PubMedCrossRef

Solomon AJ, Schindler MK, Howard DB, Watts R, Sati P, Nickerson JP, Reich DS (2015) “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol 3(2):82–87PubMedPubMedCentralCrossRef

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG (2016) The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study. Neurology 87(13):1393–1399PubMedPubMedCentralCrossRef

Straube A, Aicher B, Förderreuther S, Eggert T, Köppel J, Möller S, Schneider R, Haag G (2013) Period prevalence of self-reported headache in the general population in Germany from 1995 to 2005 and 2009: results from annual nationwide population-based cross-sectional surveys. J Headache Pain 14:14:11. https://doi.org/10.1186/1129-2377-14-11 PubMedPubMedCentralCrossRef

Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (2018) Multiple Sclerosis. Lancet 391(10130):1622–1636PubMedCrossRef

Vacca G, Marano E, Brescia Morra V, Lanzillo R, De Vito M, Parente E, Orefice G (2007) Multiple sclerosis and headache co-morbidity. A case–control study. Neurol Sci 28:133–135PubMedCrossRef

Veauthier C, Paul F (2014) Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Med. 2014 (1):5–14

Villani V, Prosperini L, Ciuffoli A, Pizzolato R, Salvetti M, Pozzilli C, Sette G (2008) Primary headache and multiple sclerosis: preliminary results of a prospective study. Neurol Sci 29:S146–S148PubMedCrossRef

Ware JE, Kosinski M, Keller SD (1996) A 12-item Short Form Health Survey: construction of scales and preliminary test of reliability and validity. Med care 34:220–233PubMedCrossRef

Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189PubMedPubMedCentralCrossRef

Zettl UK, Lehmitz R, Mix E (2009) Klinische Liquordiagnostik, 2 Auflage. Walter de Gruyter, Berlin, p 233

Zettl UK, Stüve O, Patejdl R (2012) Immune-mediated CNS diseases: a review on nosological classification and clinical features. Autoimmun Rev 11(3):167–173PubMedCrossRef

Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH (2018) Cervical spinal cord atrophy: an early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm 5(2):e435PubMedPubMedCentralCrossRef

Titel: Headache in the course of multiple sclerosis: a prospective study
verfasst von: Marcel Gebhardt
Peter Kropp
Frank Hoffmann
Uwe K. Zettl
Publikationsdatum: 30.11.2018
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 2/2019
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-018-1959-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Headache in the course of multiple sclerosis: a prospective study

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

The role of exposure to pesticides in the etiology of Parkinson’s disease: a 18F-DOPA positron emission tomography study

Effects of DRD2 splicing-regulatory polymorphism and DRD4 48 bp VNTR on crack cocaine addiction

Cerebral perfusion abnormalities in patients with persistent postural-perceptual dizziness (PPPD): a SPECT study

The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood–brain barrier breakdown in patients with paraneoplastic neurological syndromes

Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis

Complexity of electrocortical activity as potential biomarker in untreated Parkinson’s disease

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie